Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia

Clinicians and payers expect to wait and see before embracing CMS MIPS value pathways

“…Similarly, very few studies investigated insurance-related disparities in health outcomes based on race/ethnicity or on socioeconomic factors. 33,34 and 2 reported mixed findings. 35,36 All but one study reporting survival disparities were large retrospective registry studies, and overwhelmingly, they reported better survival among patients with insurance compared with those with no insurance and better survival among patients with private commercial insurance compared with other insurance types.…”

“…In contrast, the 2 studies reporting no difference in OS based on insurance type were small chart reviews. 33,34 Of the 2 studies reporting mixed survival outcomes, both were large registry database studies. One found increased OS among Medicaid-enrolled beneficiaries compared with non-Medicaid-enrolled beneficiaries (with the non-Medicaid group including both commercially insured and uninsured patients) with acute myeloid leukemia and Hodgkin lymphoma enrolled in New York State; however, there was no such difference in survival among Medicaid beneficiaries enrolled in California.…”